PI3K/AKT Signaling Pathway Mediated Autophagy in Oral Carcinoma - A Comprehensive Review

Peramaiyan Rajendran1,2, Ramya Sekar3,2, Prabhu Shankar Dhayasankar4

  • 1Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, 31982, Saudi Arabia.

Insights

This review explores the PI3K/AKT/mTOR pathway

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Oral cancer exhibits significant clinical and histological heterogeneity.
  • The PI3K/AKT/mTOR pathway is frequently dysregulated in oral cancer, controlling vital cellular functions.
  • Targeting this pathway offers potential for developing specific oral cancer therapeutics with reduced toxicity.

Purpose of the Study:

  • To elucidate the regulation of the PI3K/AKT/mTOR pathway in oral squamous cell carcinoma (OSCC).
  • To detail the pathway's role in regulating autophagy and apoptosis during OSCC progression and metastasis.
  • To identify upstream activators and downstream effectors of PI3K/AKT/mTOR signaling as therapeutic targets for oral cancer.

Main Methods:

  • Literature review focusing on PI3K/AKT/mTOR signaling in oral cancer.
  • Analysis of studies investigating pathway regulation, autophagy, and apoptosis.
  • Identification of potential therapeutic targets within the PI3K/AKT/mTOR pathway.

Main Results:

  • The PI3K/AKT/mTOR pathway is a key regulator of cellular and metabolic activities in oral cancer.
  • Dysregulation of this pathway influences autophagy and apoptosis, contributing to OSCC progression and metastasis.
  • Specific proteins within the pathway present viable targets for novel oral cancer drug development.

Conclusions:

  • The PI3K/AKT/mTOR pathway is a critical determinant in oral squamous cell carcinoma.
  • Understanding its regulatory mechanisms and downstream effects is crucial for effective oral cancer treatment strategies.
  • Targeting components of the PI3K/AKT/mTOR pathway holds promise for improving oral cancer therapy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K